| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |